BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2150635)

  • 1. Multicentre isradipine dose-confirmation study in Thai patients with hypertension.
    Tanomsup S; Tantbirojn P; Koanantakul B; Nontakanun S; Jaroonvesama N; Charoenlarp K
    Drugs; 1990; 40 Suppl 2():22-5. PubMed ID: 2150635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isradipine dose-confirmation study in Filipino patients with mild to moderate hypertension.
    Abarquez RF; Cabral EI; Namin EP; Calleja HB; Porciuncula CI; Divinagracia RA; Anastacio RV; Castillo RR
    Drugs; 1990; 40 Suppl 2():33-7. PubMed ID: 2150639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the blood pressure response to oral isradipine in uncomplicated mild-to-moderate essential hypertension.
    Leary WP; Reyes AJ; Maharaj B; van der Byl K
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):147S-150S. PubMed ID: 1827006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isradipine in Asian patients with hypertension.
    Zubair M; Karim S; Hussain S
    Drugs; 1990; 40 Suppl 2():26-9. PubMed ID: 2150636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled trial of once-a-day isradipine monotherapy in mild to moderately severe hypertension.
    Winer N; Kirkendall WM; Canosa FL; Lewin AJ; McMahon FG; Carr AA; Cohen M
    J Clin Pharmacol; 1990 Nov; 30(11):1006-11. PubMed ID: 2147029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose isradipine once daily effectively controls 24-h blood pressure in essential hypertension.
    Diemont WL; Stegeman CJ; Beekman J; Siegers AM; Hagels G; de Bruijn JH
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):163S-167S. PubMed ID: 1827011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
    Welzel D; Burger KJ
    Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
    Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
    Gómez G; Melgarejo E; Narváez J; Gamarra G; Restrepo G; Acevedo L; Izurieta A
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):128S-130S. PubMed ID: 1827002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isradipine in the treatment of mild-to-moderate hypertension in Portugal.
    Pereira-Miguel JM; Correa-Nunes A; Rocha-Gonçalves F; Mariano-Pego G
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S49-52. PubMed ID: 1376835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour blood pressure control with isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Faraggi D
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):161S-162S. PubMed ID: 1827010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
    Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
    Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of isradipine and metoprolol in treatment of hypertension: the Finnish Isradipine Study in Hypertension (FISH).
    Luomanmäki K; Inkovaara J; Hartikainen M; Helin M; Viikari J; Kataja M; Ekman K; Harjula K
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):296-303. PubMed ID: 1381022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.